Navigation Links
Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
Date:1/12/2009

ted predictive or prognostic test could be very useful in helping us optimize treatment plans for these patients, potentially sparing them from chemotherapy they do not need."

As previously announced, Genomic Health will present at the 27th Annual JPMorgan Healthcare Conference in San Francisco on Wednesday, January 14 at 10:30 a.m. Pacific Time. To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health's Web site at http://investor.genomichealth.com. Please connect to the Web site at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available for three months beginning 24 hours after the live presentation.

About Oncotype DX(R) breast cancer assay

The Oncotype DX breast cancer assay is the first and only multi-gene expression test commercially available that has clinical evidence validating its ability to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. Additionally, the test report provides quantitative scores for certain individual genes. The Oncotype DX breast cancer assay has been extensively evaluated in eleven clinical studies involving more than 4,000 breast cancer patients, including a large validation study published in The New England Journal of Medicine and a chemotherapy benefit study published in the Journal of Clinical Oncology. To date, 7,500 physicians have ordered more than 75,000 tests, and both Medicare and private health plans covering approximately 90 percent of U.S. insured lives provide reimbursement for Oncotype DX through contracts, agreements or policy decisions. Both the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
2. Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
3. AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
4. Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
5. Transgenomic Receives Accreditation From College of American Pathologists
6. Genomic Health Announces Appointment of Ginger Graham to Board of Directors
7. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
8. Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium
9. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
10. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
11. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personalize...o take place on February 22-24, 2010 in Philadelph...ce we will highlight key issues in forming partner...experiences. , Minneapoli...rrowhead’s 2010 Personalized Medicine Partn...
(Date:11/5/2009)...Nov. 5 The endangered black-footed...U.S. This rare carnivore feeds on prairie dogs. ...nd often entire population die-offs in towns occur...implemented a ferret breeding program and has been...merly native habitat. Unfortunately, plague can s...
(Date:11/5/2009)...if., Nov. 5 ThermoGenesi...novative products for processing and storing adult...quarter of fiscal 2010. ,, For the quarter ende...s of $5.2 million, a 15 percent increase over reve...go. The Company said the key contributors to the g...
(Date:11/5/2009).... 5 BioSpecifics Technol...company developing first-in-class collagenase-base...for the third quarter ended September 30, 2009. ,...f this year, the FDA,s Arthritis Advisory Committe...approval of XIAFLEX(TM) for the treatment of Dupuy...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...Expected to Yield Multiple New Drug Products for A...NTA MONICA, Calif., March 27 Aida,Pharmaceuticals...hat has,acquired one of China,s top microbiology r...biology Co., Ltd. ("JSIM") Aida,s subsidiary, Hanz...the institute from Jinou,Medicine Co., Ltd while a...
....J., March 27 Pharmasset, Inc.,(Nasdaq: VRUS ), ...developing and commercializing novel drugs to trea...ointment of Herbert J. Conrad as a member of the,B... Governance Committee.,Mr. Conrad is currently the...erapeutics, a Director of Savient Pharmaceuticals,...
...mbers aim to build business through conversion of ...nced materials, COLUMBUS, Ohio, March 27 The sta...nting a wide range of expertise in the,fields of c...e on the Ohio,Agriculture to Chemicals, Polymers, ... the task force is aimed at accelerating the state...
Other Biology Technology:Aida Acquires High-Level Research Institute in China 2Pharmasset Appoints Herbert J. Conrad as a Director 2Pharmasset Appoints Herbert J. Conrad as a Director 3Ohio Task Force Begins Mission of Creating a New 21st Century Industry 2Ohio Task Force Begins Mission of Creating a New 21st Century Industry 3
(Date:11/9/2009)...ber 09, 2009 / b3c newswire / - Today, TNO, a D...ave, an American organization for contract researc...e signed a letter of intent with regard to TNOs dy...letter of intent proposes a collaboration in which...ercialization in North America. The TIM systems wi...
(Date:11/9/2009)...009 A nutritionist whose research was instrumenta...omen, Infants and Children (WIC) food subsidy will...r outstanding achievement in the field of maternal... , a professor in the Department of Community Heal...ngeles School of Public Health, will receive the a...
(Date:11/8/2009)...D FOR ADULTS WITH INTELLECTUAL DISABILITIES: AN OP...ersity study involving adults with intellectual di...ersonal health knowledge after taking a semi-weekl...ternationally accepted term for mental retardation...inactivity and preventable chronic diseases compar...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 1Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 4Chromosomal problems affect nearly all human embryos 9081 1Chromosomal problems affect nearly all human embryos 9081 2Chromosomal problems affect nearly all human embryos 9081 3Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 1Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 2Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 3
...wn to have a profound impact on human physiology a...w, a new study led by researchers from the Biodesi... that the tiniest passengers flown in spacemicrobe...hem more infectious pathogens. , Space flight alt...auts including the immune response, said Nickerson...
...007 Men who have lower-pitched voices have more c...archers have found. And their study suggests that...ours men with low-pitched voices. , The study, pu...e evolution of the human voice as well as how we c...nberg, assistant professor in the Department of Ps...
...RELEASE , Spinning a new role for CDs and CD pla...d the hardware used to play these popular audio an...l as a new generation of portable, inexpensive ins...y-based testing, scientists in Spain are reporting... a semi-monthly journal. CD technology could be a...
Other Biology News:Spaceflight shown to alter ability of bacteria to cause disease 2Spaceflight shown to alter ability of bacteria to cause disease 3Spaceflight shown to alter ability of bacteria to cause disease 4American Chemical Society's Weekly PressPac -- Sept. 19, 2007 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 3American Chemical Society's Weekly PressPac -- Sept. 19, 2007 4American Chemical Society's Weekly PressPac -- Sept. 19, 2007 5American Chemical Society's Weekly PressPac -- Sept. 19, 2007 6American Chemical Society's Weekly PressPac -- Sept. 19, 2007 7American Chemical Society's Weekly PressPac -- Sept. 19, 2007 8
...abolite postulated to play an autacoid role in the...icrovessels, 20-HETE is a vasoconstrictor that med...tion. 20-HETE is excreted mainly as the glucuronid...-40 pg/ml in human urine) is about 10-fold lower t...
...to insert a transposable element of your own desig.... It uses TnsABC* Transposase to insert a Tn7-base...t DNA may be a plasmid, cosmid, BAC or purified,.... If the insertion site is within a translated gen...
...he several main MAP kinase groups Firefly lucifera...ing gene regulation and function. Luciferase provi...son to the standard chloramphenicol acetyltransfer...oxidative carboxylation of luciferin, a reaction w...
... PCR system that ensures successful PCR, the first...tency, and dependability for PCR, regardless of th...s system uses EPICENTRE's FailSafe™ PCR Enzym... is capable of amplifying the most difficult DNA t...
Biology Products: